On ECHEMI
Home > Drugs > Isoladine Maleate

Isoladine Maleate

Function and Efficacy

This product is a gastric mucosal protective agent. It strengthens the combination between gastric mucosal epithelial cells, inhibits the peeling and shedding of epithelial cells and the expansion of cell gaps, enhances the stability of mucosal cells themselves, plays a mucosal defense role, and inhibits harmful substances from passing through the mucosa. Its mechanism of action is related to increasing the content of CAMP, prostaglandins, reduced glutathione and mucus glycoprotein in gastric mucosal cells. Experiments show that this product can inhibit gastric mucosal cell disorders caused by hydrochloric acid and ethanol, and also has the effect of increasing gastric mucosal blood flow. The effect is dose-dependent.

Ingredients

Isoladine maleate.

Name Description Content CAS NO. Manufacturer
Irsogladine maleateIngredients

This product is a gastric mucosal protective agent. It strengthens the combination between gastric mucosal epithelial cells, inhibits the peeling and shedding of epithelial cells and the expansion of cell gaps, enhances the stability of mucosal cells themselves, plays a mucosal defense role, and inhibits harmful substances from passing through the mucosa. Its mechanism of action is related to increasing the content of CAMP, prostaglandins, reduced glutathione and mucus glycoprotein in gastric mucosal cells. Experiments show that this product can inhibit gastric mucosal cell disorders caused by hydrochloric acid and ethanol, and also has the effect of increasing gastric mucosal blood flow. The effect is dose-dependent.

More
84504-69-8 5

Indication

Gastric ulcer, improve gastric mucosal lesions (erosion, bleeding, redness, edema) in acute gastritis and acute attack of chronic gastritis.

Usage and Dosage

Oral administration: 4 mg per day, divided into 1 to 2 doses. The dosage can be appropriately increased or decreased according to age and symptoms.

Adverse Reactions

Occasionally, there may be dizziness, nausea, vomiting, constipation, diarrhea, rash, loss of appetite, upper abdominal discomfort, and occasionally a mild reversible increase in aminotransferase.

Precautions

Not yet clear

Drug Interactions

Not yet clear

Storage

Store in airtight, dry place

Manufacturer

Qilu Pharmaceutical Co., Ltd.

  • Founded in:

    1992-08-21
  • Address:

    No. 317, Xinluo Street, High-tech Zone, Jinan City, Shandong Province
  • Tax NO.:

    91370000614073351Q
  • Registered Funds:

    600 million yuan
  • Website:

  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.